{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 457636417
| drug_name = Fludrocortisone
| IUPAC_name = (8''S'',9''R'',10''S'',11''S'',13''S'',14''S'',17''R'')-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[''a'']phenanthren-3-one
| image = Fludrocortisone.svg
| width = 200px
| image2 = Fludrocortisone-from-xtal-1972-3D-balls.png
| width2 = 225px

<!--Clinical data-->
| tradename = Astonin, Astonin-H, others
| Drugs.com = {{drugs.com|monograph|florinef-acetate}}
| pregnancy_category = C
| legal_US = Rx-only
| routes_of_administration = [[Oral administration|By mouth]]

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = High
| metabolism = [[Liver]]
| elimination_half-life = 3.5 hours

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 127-31-1
| class = [[Corticosteroid]]; [[glucocorticoid]]
| ATC_prefix = H02
| ATC_suffix = AA02
| ATC_supplemental = 
| PubChem = 31378
| IUPHAR_ligand = 2873
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00687
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 29111
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = U0476M545B
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07967
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 50885
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201388

<!--Chemical data-->
| C=21 | H=29 | F=1 | O=5
| molecular_weight = 380.45 g/mol
| SMILES = O=C(CO)[C@]3(O)[C@]2(C[C@H](O)[C@]4(F)[C@@]1(/C(=C\C(=O)CC1)CC[C@H]4[C@@H]2CC3)C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C21H29FO5/c1-18-7-5-13(24)9-12(18)3-4-15-14-6-8-20(27,17(26)11-23)19(14,2)10-16(25)21(15,18)22/h9,14-16,23,25,27H,3-8,10-11H2,1-2H3/t14-,15-,16-,18-,19-,20-,21-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = AAXVEMMRQDVLJB-BULBTXNYSA-N
| synonyms = <small>StC-1400; 9α-Fluorohydrocortisone; 9α-Fluorocortisol; 9α-Fluoro-17α-hydroxycorticosterone; 9α-Fluoro-11β,17α,21-trihydroxypregn-4-ene-3,20-dione</small>
}}
{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| drug_name = Fludrocortisone acetate
| IUPAC_name = [2-[(8''S'',9''R'',10''S'',11''S'',13''S'',14''S'',17''R'')-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[''a'']phenanthren-17-yl]-2-oxoethyl] acetate
| image = Fludrocortisone acetate.svg
| width = 

<!--Clinical data-->
| tradename = Cortineff, Florinef, Florinefe, Fludrocortison, others
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = [[Oral administration|By mouth]]

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = [[Liver]]
| elimination_half-life = 
| excretion =

<!-- Identifiers -->
| CAS_number_Ref = 
| CAS_number = 514-36-3
| CAS_supplemental = 
| class = [[Corticosteroid]]; [[glucocorticoid]]
| ATC_prefix = 
| ATC_suffix = 
| ATC_supplemental = 
| PubChem = 225609
| IUPHAR_ligand = 
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 196144
| UNII = V47IF0PVH4
| KEGG = 
| ChEBI = 
| ChEMBL = 

<!--Chemical data-->
| C=23 | H=31 | F=1 | O=6
| molecular_weight = 422.493 g/mol
| SMILES = CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)CC[C@@]43C)F)O)C)O
| StdInChI_Ref = 
| StdInChI = 1S/C23H31FO6/c1-13(25)30-12-19(28)22(29)9-7-16-17-5-4-14-10-15(26)6-8-20(14,2)23(17,24)18(27)11-21(16,22)3/h10,16-18,27,29H,4-9,11-12H2,1-3H3/t16-,17-,18-,20-,21-,22-,23-/m0/s1
| StdInChIKey_Ref = 
| StdInChIKey = SYWHXTATXSMDSB-GSLJADNHSA-N
| synonyms = <small>Fluorohydrocortisone acetate; 9α-Fluorohydrocortisone 21-acetate; 9α-Fluoro-17α-hydroxycorticosterone 21-acetate; 9α-Fluoro-11β,17α,21-trihydroxypregn-4-ene-3,20-dione 21-acetate</small>
}}
<!-- Definition and medical uses -->
'''Fludrocortisone''', sold under the brand name '''Florinef''' among others, is a [[corticosteroid]] which is used to treat [[adrenogenital syndrome]], [[postural hypotension]], and [[adrenal insufficiency]].<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA558|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=558–}}</ref><ref name="IndexNominum2000">{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA450|year=2000|publisher=Taylor & Francis|isbn=978-3-88763-075-1|pages=450–}}</ref><ref name=AHFS2016/> In adrenal insufficiency it is generally taken together with [[hydrocortisone]].<ref name=AHFS2016/> It is taken by mouth.<ref name=AHFS2016>{{cite web|title=Fludrocortisone Acetate|url=https://www.drugs.com/monograph/fludrocortisone-acetate.html|publisher=The American Society of Health-System Pharmacists|accessdate= 8 December 2016}}</ref> The medication is most commonly used in its [[acetate]] form.<ref name=DayFurst2010>{{cite book|author1=Richard O. Day|author2=Daniel E. Furst|author3=Piet L.C.M. van Riel|author4=Barry Bresnihan|title=Antirheumatic Therapy: Actions and Outcomes|url=https://books.google.com/books?id=OqKTuL9ePhsC&pg=PA21|date=30 May 2010|publisher=Springer Science & Business Media|isbn=978-3-7643-7726-7|pages=21–}}</ref>

<!-- Side effects and mechanism -->
Common side effects include [[high blood pressure]], swelling, [[heart failure]], and [[low blood potassium]].<ref name=AHFS2016/> Other serious side effects include [[immunosuppression|low immune system function]], [[cataracts]], muscle weakness, and mood changes.<ref name=AHFS2016/> It is unclear if use during [[pregnancy]] is safe for the baby.<ref>{{cite web|title=Fludrocortisone Use During Pregnancy {{!}} Drugs.com|url=https://www.drugs.com/pregnancy/fludrocortisone.html|website=www.drugs.com|accessdate=24 December 2016}}</ref> Fludrocortisone is mostly a [[mineralocorticoid]]; however, also has [[glucocorticoid]] effects.<ref name=AHFS2016/>

<!-- Society and culture -->
Fludrocortisone was patented in 1953.<ref name=Fis2006>{{cite book|last1=Fischer|first1=Janos|last2=Ganellin|first2=C. Robin|title=Analogue-based Drug Discovery|date=2006|publisher=John Wiley & Sons|isbn=9783527607495|page=484|url=https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA484|language=en}}</ref> It is on the [[World Health Organization's List of Essential Medicines]], the most effective and safe medicines needed in a [[health system]].<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=8 December 2016|date=April 2015}}</ref> In the United Kingdom it costs the [[NHS]] about 1.52 pounds per month.<ref name=BNF69>{{cite book|title=British national formulary : BNF 69|date=2015|publisher=British Medical Association|isbn=9780857111562|page=494|edition=69}}</ref> In the United States the wholesale cost of a month of medications is about 11.96 USD.<ref>{{cite web|title=NADAC as of 2016-12-21 {{!}} Data.Medicaid.gov|url=https://data.medicaid.gov/Drug-Prices/NADAC-as-of-2016-12-21/6ebu-k7ew|website=Centers for Medicare and Medicaid Services|accessdate=24 December 2016}}</ref>

==Medical uses==
Fludrocortisone has been used in the treatment of [[cerebral salt wasting|cerebral salt wasting syndrome]].<ref name="pmid17101713">{{cite journal |vauthors=Taplin CE, Cowell CT, Silink M, Ambler GR |title=Fludrocortisone therapy in cerebral salt wasting |journal=Pediatrics |volume=118 |issue=6 |pages=e1904–8 |date=December 2006 |pmid=17101713 |doi=10.1542/peds.2006-0702 |url=http://pediatrics.aappublications.org/cgi/pmidlookup?view=long&pmid=17101713}}</ref>  It is used primarily to replace the missing hormone [[aldosterone]] in various forms of [[adrenal insufficiency]] such as [[Addison's disease]] and the classic salt wasting ([[21-hydroxylase deficiency]]) form of [[congenital adrenal hyperplasia]].  Due to its effects on increasing Na+ levels, and therefore blood volume, fludrocortisone is the first line of treatment for [[orthostatic intolerance]] and [[postural orthostatic tachycardia syndrome]] (POTS).<ref>{{cite journal |vauthors=Freitas J, Santos R, Azevedo E, Costa O, Carvalho M, Falcão de Freitas A |url=https://dx.doi.org/10.1007/BF02281112|title=Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone|journal=Clinical Autonomic Research|volume=10|number=5|year=2000|doi=10.1007/BF02281112|pages=293–299}}</ref>
It can be used to treat low blood pressure.

Fludrocortisone is also a confirmation test for diagnosing [[Conn's syndrome]] (aldosterone producing-adrenal adenoma), the fludrocortisone suppression test. Loading the patient with fludrocortisone would ''suppress'' serum aldosterone level in a normal patient, whereas the level would remain ''elevated'' in a Conn's patient.  The fludrocortisone suppression test is an alternative to the NaCl challenge (which would use normal saline or NaCl tablets).

==Side effects==
* Sodium and water retention
* Swelling due to fluid retention ([[edema]])
* High blood pressure ([[hypertension]])
* Headache
* Low blood potassium level ([[hypokalemia]])
* Muscle weakness
* Fatigue
* Increased susceptibility to infection
* Impaired wound healing
* Increased sweating
* Increased hair growth ([[hirsutism]])
* Thinning of skin and stretch marks
* Disturbances of the gut such as indigestion ([[dyspepsia]]), distention of the abdomen and ulceration ([[peptic ulcer]])
* Decreased bone density and increased risk of fractures of the bones
* Difficulty in sleeping ([[insomnia]])
* Depression
* Weight gain
* Raised blood sugar level
* Changes to the menstrual cycle
* Partial loss of vision due to opacity in the lens of the eye ([[cataracts]])
* Raised pressure in the eye ([[glaucoma]])
* Increased pressure in the skull ([[intracranial pressure]])

==Pharmacology==
Fludrocortisone is a [[corticosteroid]] and acts as a powerful [[mineralocorticoid]] along with some additional but comparatively very weak [[glucocorticoid]] activity.<ref name="pmid25905379">{{cite journal | vauthors = De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Chrousos, Pavlaki AN, Magiakou MA | title = Glucocorticoid Therapy and Adrenal Suppression | journal = | volume = | issue = | pages = | year = | pmid = 25905379 | doi = | url = }}</ref> Relative to cortisol, it is said to have 10&nbsp;times the glucocorticoid [[potency (pharmacology)|potency]] but 250 to 800&nbsp;times the mineralocorticoid potency.<ref name="pmid25905379" /><ref name="LemkeWilliams2008" /> Fludrocortisone acetate is a [[prodrug]] of fludrocortisone, which is the active form of the drug.<ref name="pmid27416887">{{cite journal | vauthors = Polito A, Hamitouche N, Ribot M, Polito A, Laviolle B, Bellissant E, Annane D, Alvarez JC | title = Pharmacokinetics of oral fludrocortisone in septic shock | journal = Br J Clin Pharmacol | volume = 82 | issue = 6 | pages = 1509–1516 | year = 2016 | pmid = 27416887 | doi = 10.1111/bcp.13065 | url = }}</ref>

Renin plasma, sodium, and potassium is checked through blood tests in order to verify that the correct dosage is reached.

==Chemistry==
Fludrocortisone, also known as 9α-fluorocortisol (9α-fluorohydrocortisone) or as 9α-fluoro-11β,17α,21-trihydroxypregn-4-ene-3,20-dione, is a [[synthetic compound|synthetic]] [[pregnane]] [[steroid]] and a [[halogen]]ated [[chemical derivative|derivative]] of [[cortisol]] (11β,17α,21-trihydroxypregn-4-ene-3,20-dione).<ref name="Elks2014" /><ref name="IndexNominum2000" /> Specifically, it is a modification of cortisol with a [[fluorine]] atom [[substituent|substituted]] in place of one [[hydrogen]] atom at the C9α position.<ref name="Elks2014" /><ref name="IndexNominum2000" /> Fluorine is a good [[bioisostere]] for hydrogen because it is similar in size, with the major difference being in its [[electronegativity]]. The acetate form of fludrocortisone, fludrocortisone acetate, is the C21 [[acetate]] [[ester]] of fludrocortisone,<ref name="Elks2014" /><ref name="IndexNominum2000" /> and is [[hydrolysis|hydrolyzed]] into fludrocortisone in the body.<ref name="pmid27416887" />

==History==
Fludrocortisone was described in the literature in 1953<ref name="pmid13875857">{{cite journal | vauthors = CALVERT DN | title = Anti-inflammatory steroids | journal = Wis. Med. J. | volume = 61 | issue = | pages = 403–4 | year = 1962 | pmid = 13875857 | doi = | url = }}</ref> and was introduced for medical use (as the acetate ester) in 1954.<ref name="LemkeWilliams2008">{{cite book|author1=Thomas L. Lemke|author2=David A. Williams|title=Foye's Principles of Medicinal Chemistry|url=https://books.google.com/books?id=R0W1ErpsQpkC&pg=PA890|year=2008|publisher=Lippincott Williams & Wilkins|isbn=978-0-7817-6879-5|pages=890–}}</ref><ref name="Publishing2013">{{cite book|author=William Andrew Publishing|title=Pharmaceutical Manufacturing Encyclopedia, 3rd Edition|url=https://books.google.com/books?id=_J2ti4EkYpkC&pg=PA1642|date=22 October 2013|publisher=Elsevier|isbn=978-0-8155-1856-3|pages=1642–}}</ref> It was the first synthetic corticosteroid to be marketed, and followed the introduction of [[cortisone]] in 1948 and [[hydrocortisone]] (cortisol) in 1951.<ref name="pmid13875857" /><ref name="pmid16178782">{{cite journal | vauthors = Khan MO, Park KK, Lee HJ | title = Antedrugs: an approach to safer drugs | journal = Curr. Med. Chem. | volume = 12 | issue = 19 | pages = 2227–39 | year = 2005 | pmid = 16178782 | doi = | url = }}</ref> Fludrocortisone was also the first fluorine-containing pharmaceutical drug to be marketed.<ref name="pmid24776946">{{cite journal | vauthors = Walker MC, Chang MC | title = Natural and engineered biosynthesis of fluorinated natural products | journal = Chem Soc Rev | volume = 43 | issue = 18 | pages = 6527–36 | year = 2014 | pmid = 24776946 | doi = 10.1039/c4cs00027g | url = }}</ref>

==Society and culture==

===Generic name===
''Fludrocortisone'' is the [[generic term|generic name]] of fludrocortisone and its {{abbrlink|INN|International Nonproprietary Name}}, {{abbrlink|USAN|United States Adopted Name}}, {{abbrlink|BAN|British Approved Name}}, {{abbrlink|DCF|Dénomination Commune Française}}, and {{abbrlink|DCIT|Denominazione Comune Italiana}}, whereas ''fludrocortisone acetate'' is the generic name of fludrocortisone acetate and its {{abbrlink|USP|United States Pharmacopeia}}, {{abbrlink|BANM|British Approved Name}} and {{abbrlink|JAN|Japanese Accepted Name}}.<ref name="Elks2014" /><ref name="IndexNominum2000" /><ref name="Drugs.com">https://www.drugs.com/international/fludrocortisone.html</ref>

===Brand names===
Fludrocortisone is marketed mainly under the brand names Astonin and Astonin-H, whereas the more widely used fludrocortisone acetate is sold mainly as Florinef but also under several other brand names including Cortineff, Florinefe, and Fludrocortison.<ref name="IndexNominum2000" /><ref name="Drugs.com" />

===Availability===
Fludrocortisone is marketed in [[Austria]], [[Croatia]], [[Denmark]], [[Germany]], [[Luxembourg]], [[Romania]], and [[Spain]], whereas fludrocortisone acetate is more widely available throughout the world and is marketed in the [[United States]], [[Canada]], the [[United Kingdom]], various other [[Europe]]an countries, [[Australia]], [[Japan]], [[China]], [[Brazil]], and many other countries.<ref name="IndexNominum2000" /><ref name="Drugs.com" />

==References==
{{Reflist|32em}}

{{Glucocorticoids and antiglucocorticoids}}
{{Mineralocorticoids and antimineralocorticoids}}
{{Glucocorticoid receptor modulators}}
{{Mineralocorticoid receptor modulators}}

[[Category:Acetate esters]]
[[Category:Corticosteroid esters]]
[[Category:Corticosteroids]]
[[Category:Diketones]]
[[Category:Fluoroarenes]]
[[Category:Glucocorticoids]]
[[Category:Halohydrins]]
[[Category:Mineralocorticoids]]
[[Category:Organofluorides]]
[[Category:Pregnanes]]
[[Category:Prodrugs]]
[[Category:Triols]]
[[Category:World Health Organization essential medicines]]
[[Category:RTT]]